Aihc Master Fund - Net Worth and Insider Trading
Aihc Master Fund Net Worth
The estimated net worth of Aihc Master Fund is at least $212 Million dollars as of 2024-11-07. Aihc Master Fund is the 2101 Beneficial owner of Zylox-Tonbridge Medical Technology Co Ltd and owns about 19,657,020 shares of Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) stock worth over $212 Million. Details can be seen in Aihc Master Fund's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aihc Master Fund has not made any transactions after 2023-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aihc Master Fund
Aihc Master Fund Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aihc Master Fund owns 1 companies in total, including Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) .
Click here to see the complete history of Aihc Master Fund’s form 4 insider trades.
Insider Ownership Summary of Aihc Master Fund
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:02190 | Zylox-Tonbridge Medical Technology Co Ltd | 2023-09-29 | 2101 Beneficial owner |
Aihc Master Fund Latest Holdings Summary
Aihc Master Fund currently owns a total of 1 stock. Aihc Master Fund owns 19,657,020 shares of Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) as of September 29, 2023, with a value of $212 Million.
Latest Holdings of Aihc Master Fund
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:02190 | Zylox-Tonbridge Medical Technology Co Ltd | 2023-09-29 | 19,657,020 | 10.78 | 211,902,676 |
Holding Weightings of Aihc Master Fund
Aihc Master Fund Form 4 Trading Tracker
According to the SEC Form 4 filings, Aihc Master Fund has made a total of 2 transactions in Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zylox-Tonbridge Medical Technology Co Ltd is the acquisition of 391,500 shares on September 29, 2023, which cost Aihc Master Fund around $3 Million.
Insider Trading History of Aihc Master Fund
- 1
Aihc Master Fund Trading Performance
GuruFocus tracks the stock performance after each of Aihc Master Fund's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aihc Master Fund is 58.67%. GuruFocus also compares Aihc Master Fund's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aihc Master Fund within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aihc Master Fund's insider trading performs compared to the benchmark.
Performance of Aihc Master Fund
Aihc Master Fund Ownership Network
Ownership Network List of Aihc Master Fund
Ownership Network Relation of Aihc Master Fund
Aihc Master Fund Owned Company Details
What does Zylox-Tonbridge Medical Technology Co Ltd do?
Who are the key executives at Zylox-Tonbridge Medical Technology Co Ltd?
Aihc Master Fund is the 2101 Beneficial owner of Zylox-Tonbridge Medical Technology Co Ltd. Other key executives at Zylox-Tonbridge Medical Technology Co Ltd include 2501 Other Gan Zhou Ti Tan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo , 2501 Other Su Zhou Tai Hong Jing Hui Tou Zi Zhong Xin You Xian He Huo , and 2501 Other Five Investment Limited .
Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) Insider Trades Summary
Over the past 18 months, Aihc Master Fund made 1 insider transaction in Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) with a net purchase of 391,500. Other recent insider transactions involving Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) include a net sale of 3,178,727 shares made by Wang Stephen Hui , a net purchase of 391,500 shares made by Zhang Wei , and a net purchase of 391,500 shares made by Aih Capital Group Limited .
In summary, during the past 3 months, insiders sold 0 shares of Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,178,727 shares of Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) were sold and 1,174,500 shares were bought by its insiders, resulting in a net sale of 2,004,227 shares.
Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zylox-Tonbridge Medical Technology Co Ltd Insider Transactions
Aihc Master Fund Mailing Address
Above is the net worth, insider trading, and ownership report for Aihc Master Fund. Currently GuruFocus does not have mailing address information for Aihc Master Fund.